牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

荣昌生物（688331）

5.5

综合诊断：5.5分打败了98%的股票！

卖出
减持
中性
增持
买入

短期趋势：
该股进入多头行情中，股价短线上涨概率较大。
中期趋势：
-
长期趋势：
已有266家主力机构披露2024-12-31报告期持股数据，持仓量总计9259.67万股，占流通A股57.18%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.8分

5.2分

5.5分

4.5分

6.8分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.8技术面打败了95%的股票技术面评分前10的股票

近期的平均成本为70.09元。

技术面得分最高的股票

平均成本

近期的平均成本为70.09元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"70.09","date":1751532590,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。

[{"date":"2025.07.04","stock":"10.65","trade":"0.46","ind":"0.32"},{"date":"2025.07.03","stock":"2.63","trade":"2.86","ind":"0.18"},{"date":"2025.07.02","stock":"-8.19","trade":"-1.57","ind":"-0.09"},{"date":"2025.07.01","stock":"13.04","trade":"2.52","ind":"0.39"},{"date":"2025.06.30","stock":"-1.80","trade":"1.47","ind":"0.59"},{"date":"2025.06.27","stock":"1.50","trade":"0.85","ind":"-0.70"},{"date":"2025.06.26","stock":"-18.36","trade":"-1.31","ind":"-0.22"},{"date":"2025.06.25","stock":"5.61","trade":"0.29","ind":"1.03"},{"date":"2025.06.24","stock":"6.38","trade":"1.81","ind":"1.15"},{"date":"2025.06.23","stock":"5.35","trade":"1.50","ind":"0.65"},{"date":"2025.06.20","stock":"3.39","trade":"0.27","ind":"-0.07"},{"date":"2025.06.19","stock":"-3.66","trade":"-1.80","ind":"-0.79"},{"date":"2025.06.18","stock":"2.27","trade":"-1.20","ind":"0.04"},{"date":"2025.06.17","stock":"-5.99","trade":"-1.63","ind":"-0.04"},{"date":"2025.06.16","stock":"1.11","trade":"-0.12","ind":"0.35"},{"date":"2025.06.13","stock":"-8.62","trade":"-2.82","ind":"-0.75"},{"date":"2025.06.12","stock":"17.55","trade":"1.54","ind":"0.01"},{"date":"2025.06.11","stock":"-4.13","trade":"-1.03","ind":"0.52"},{"date":"2025.06.10","stock":"2.29","trade":"1.10","ind":"-0.44"},{"date":"2025.06.09","stock":"0.97","trade":"2.75","ind":"0.43"},{"date":"2025.06.06","stock":"-0.81","trade":"0.34","ind":"0.04"}]

荣昌生物,上证指数,生物制品指数

压力支撑

该股压力位为69.59元，支撑位为66.01元。

[{"text":"\u538b\u529b\u4f4d","value":"69.59","date":1751558400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"66.01","date":1751558400,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.2资金面打败了87%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：07月04日 20:31

机构今日流向(万元)	-272.71	机构5日流向(万元)	1476.86
机构10日流向(万元)	-818.41	机构20日流向(万元)	-13069.79

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少1387.45万股，其中基金净增仓15家，主力净减仓11家，暂未发现中长期投资价值。

截止2024-12-31，共266家主力机构（基金263家，QFII1家，一般法人2家），持仓量总计9259.67万股，占流通A股57.18%
其中，基金持仓与2024-06-30相比：
增仓：74家，增持 1173.10万股
减仓：59家，减持 1469.92万股
新出现在主力名单中：113家，持有707.71万股
从主力名单中消失：124家，原持有1798.34万股

消息面诊股

诊断结果：5.5消息面打败了76%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	外资股类别股东大会	2025-05-27
一般消息	高管变动	委员会调整	2025-05-26
一般消息	分红转增	不分配不转增	2025-03-28
一般消息	募资投向		2025-03-27
一般消息	高管变动	因个人职业发展	2025-02-06
利好	业绩预告	预计减亏	2025-01-17
一般消息	高管变动	根据中国科学院院士兼职管理的相关规...	2025-01-10
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-12-31
一般消息	分红转增	不分配不转增	2024-08-17
一般消息	高管变动	不再担任	2024-08-09

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：4.5行业面打败了64%的股票生物制品行业最新资金流向

近10日来该行业走势明显向上，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势明显向上，跑赢大盘。

[{"date":"2025.07.04","price":"0.32","value":"0.46"},{"date":"2025.07.03","price":"0.18","value":"2.86"},{"date":"2025.07.02","price":"-0.09","value":"-1.57"},{"date":"2025.07.01","price":"0.39","value":"2.52"},{"date":"2025.06.30","price":"0.59","value":"1.47"},{"date":"2025.06.27","price":"-0.70","value":"0.85"},{"date":"2025.06.26","price":"-0.22","value":"-1.31"},{"date":"2025.06.25","price":"1.03","value":"0.29"},{"date":"2025.06.24","price":"1.15","value":"1.81"},{"date":"2025.06.23","price":"0.65","value":"1.50"},{"date":"2025.06.20","price":"-0.07","value":"0.27"},{"date":"2025.06.19","price":"-0.79","value":"-1.80"},{"date":"2025.06.18","price":"0.04","value":"-1.20"},{"date":"2025.06.17","price":"-0.04","value":"-1.63"},{"date":"2025.06.16","price":"0.35","value":"-0.12"},{"date":"2025.06.13","price":"-0.75","value":"-2.82"},{"date":"2025.06.12","price":"0.01","value":"1.54"},{"date":"2025.06.11","price":"0.52","value":"-1.03"},{"date":"2025.06.10","price":"-0.44","value":"1.10"},{"date":"2025.06.09","price":"0.43","value":"2.75"},{"date":"2025.06.06","price":"0.04","value":"0.34"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	神州细胞	83.91%	45.01%	5.7分
2	赛升药业	46.31%	10.62%	4.8分
3	未名医药	34.23%	24.66%	4.3分
4	百普赛斯	32.79%	16.44%	5.7分
5	君实生物	21.52%	18.93%	5.6分
6	荣昌生物	16.89%	15.73%	5.5分
7	*ST四环	12.61%	0.00%	4.3分
8	近岸蛋白	12.58%	10.89%	4.0分
9	康辰药业	12.38%	9.25%	5.4分
10	康华生物	10.30%	-3.24%	4.9分
11	迈威生物	9.78%	7.02%	4.5分
12	义翘神州	8.52%	6.39%	5.1分
13	通化东宝	7.89%	0.88%	4.9分
14	万泽股份	7.51%	3.26%	5.6分
15	沃森生物	7.04%	1.56%	4.3分
16	艾迪药业	6.95%	12.27%	5.3分
17	长春高新	5.86%	10.67%	5.3分
18	金迪克	5.58%	2.34%	4.5分
19	康泰生物	5.51%	0.00%	4.5分
20	派林生物	4.52%	-1.26%	4.3分
21	我武生物	3.10%	4.62%	5.3分
22	百奥泰	2.22%	8.79%	5.1分
23	东宝生物	2.16%	-1.39%	4.4分
24	辽宁成大	1.94%	-0.81%	4.7分
25	华兰疫苗	1.63%	2.62%	4.5分
26	优宁维	1.61%	0.90%	4.7分
27	甘李药业	1.52%	4.74%	5.0分
28	康希诺	1.29%	3.08%	4.6分
29	昊帆生物	1.13%	5.34%	4.8分
30	百克生物	0.72%	1.54%	4.1分
31	智飞生物	0.51%	0.93%	4.1分
32	博晖创新	0.17%	2.23%	4.4分
33	安科生物	-0.11%	5.98%	5.5分
34	卫光生物	-0.34%	2.71%	4.8分
35	康弘药业	-0.40%	5.23%	5.5分
36	华兰生物	-0.75%	1.08%	4.7分
37	西藏药业	-0.94%	0.33%	4.5分
38	智翔金泰	-1.83%	6.60%	4.4分
39	上海莱士	-2.14%	-0.58%	4.7分
40	特宝生物	-2.36%	-0.29%	5.2分
41	凯因科技	-3.02%	-2.18%	4.4分
42	天坛生物	-3.24%	1.15%	4.5分
43	博雅生物	-5.32%	0.04%	4.7分
44	*ST双成	-5.96%	6.33%	4.6分
45	赛伦生物	-8.18%	4.28%	4.2分
46	欧林生物	-8.54%	3.37%	4.5分
47	三生国健	-10.91%	3.73%	5.2分
48	-	-14.94%	-0.12%	分
49	成大生物	-65.80%	-0.72%	4.2分
50	诺唯赞	-72.76%	0.53%	4.1分
51	诺诚健华	-	4.69%	5.1分
52	科兴制药	-	30.08%	5.6分

<上一页 1 2 3 4 5...9 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.8基本面打败了84%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（27.5分）

基本面得分最高的股票

[ 截止日期：2025-03-31 ]公司经营

盈利能力：尚可，接近行业平均，两项指标的行业排名分别为 49/72 ， 15/72。

[{"date":"2025-03-31","value":"-13.53","vol":"0.63"},{"date":"2024-12-31","value":"-54.15","vol":"-0.24"},{"date":"2024-09-30","value":"-36.91","vol":"1.37"},{"date":"2024-06-30","value":"-25.58","vol":"0.72"},{"date":"2024-03-31","value":"-10.71","vol":"0.41"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净资产收益率(%)	-13.53	-54.15	-36.91	-25.58	-10.71
行业(%)	0.63	-0.24	1.37	0.72	0.41

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"83.26","vol":"69.78"},{"date":"2024-12-31","value":"80.36","vol":"69.97"},{"date":"2024-09-30","value":"79.75","vol":"70.57"},{"date":"2024-06-30","value":"78.27","vol":"69.89"},{"date":"2024-03-31","value":"77.50","vol":"70.42"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
销售毛利率(%)	83.26	80.36	79.75	78.27	77.50
行业(%)	69.78	69.97	70.57	69.89	70.42

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，两项指标的行业排名分别为 5/72 ， 12/72。

[{"date":"2025-03-31","value":"59.17","vol":"6246.12"},{"date":"2024-12-31","value":"58.54","vol":"48.20"},{"date":"2024-09-30","value":"57.10","vol":"178.44"},{"date":"2024-06-30","value":"75.59","vol":"19.75"},{"date":"2024-03-31","value":"96.41","vol":"31.66"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
营业收入同比增长率(%)	59.17	58.54	57.10	75.59	96.41
行业(%)	6246.12	48.20	178.44	19.75	31.66

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"27.16","vol":"-7.36"},{"date":"2024-12-31","value":"2.84","vol":"-10.38"},{"date":"2024-09-30","value":"-3.96","vol":"-53.42"},{"date":"2024-06-30","value":"-10.96","vol":"-9.25"},{"date":"2024-03-31","value":"-7.77","vol":"-535.57"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
净利润同比增长率(%)	27.16	2.84	-3.96	-10.96	-7.77
行业(%)	-7.36	-10.38	-53.42	-9.25	-535.57

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，两项指标的行业排名分别为 8/72 ， 36/72。

[{"date":"2025-03-31","value":"0.10","vol":"0.06"},{"date":"2024-12-31","value":"0.31","vol":"0.29"},{"date":"2024-09-30","value":"0.22","vol":"0.22"},{"date":"2024-06-30","value":"0.13","vol":"0.14"},{"date":"2024-03-31","value":"0.06","vol":"0.07"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
总资产周转率(次)	0.10	0.31	0.22	0.13	0.06
行业(次)	0.06	0.29	0.22	0.14	0.07

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.14","vol":"0.26"},{"date":"2024-12-31","value":"0.48","vol":"1.19"},{"date":"2024-09-30","value":"0.33","vol":"0.87"},{"date":"2024-06-30","value":"0.22","vol":"0.55"},{"date":"2024-03-31","value":"0.10","vol":"0.26"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
存货增长率(次)	0.14	0.48	0.33	0.22	0.10
行业(次)	0.26	1.19	0.87	0.55	0.26

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-03-31","value":"-35.80","vol":"-47.52"},{"date":"2024-12-31","value":"-54.96","vol":"-9.01"},{"date":"2024-09-30","value":"-3.20","vol":"-29.47"},{"date":"2024-06-30","value":"-95.76","vol":"-36875.39"},{"date":"2024-03-31","value":"-129.01","vol":"-44804.94"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
现金流量净额/营业收入	-35.80	-54.96	-3.20	-95.76	-129.01
行业	-47.52	-9.01	-29.47	-36875.39	-44804.94

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.88","vol":"2.00"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.98","vol":"2.72"},{"date":"2024-03-31","value":"","vol":"0.00"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资本支出／折旧和摊销	-	0.88	-	0.98	-
行业	0.00	2.00	0.00	2.72	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 17/72 ， 11/72。

[{"date":"2025-03-31","value":"0.92","vol":"7.90"},{"date":"2024-12-31","value":"1.05","vol":"6.83"},{"date":"2024-09-30","value":"1.36","vol":"7.16"},{"date":"2024-06-30","value":"1.52","vol":"7.04"},{"date":"2024-03-31","value":"1.72","vol":"8.08"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
流动比率	0.92	1.05	1.36	1.52	1.72
行业	7.90	6.83	7.16	7.04	8.08

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"0.56","vol":"6.47"},{"date":"2024-12-31","value":"0.64","vol":"5.50"},{"date":"2024-09-30","value":"0.80","vol":"5.77"},{"date":"2024-06-30","value":"0.88","vol":"5.91"},{"date":"2024-03-31","value":"0.89","vol":"6.93"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
速动比率	0.56	0.64	0.80	0.88	0.89
行业	6.47	5.50	5.77	5.91	6.93

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 12/72 ， 4/72。

[{"date":"2025-03-31","value":"66.62","vol":"25.48"},{"date":"2024-12-31","value":"63.88","vol":"25.46"},{"date":"2024-09-30","value":"58.54","vol":"24.92"},{"date":"2024-06-30","value":"53.70","vol":"24.62"},{"date":"2024-03-31","value":"43.81","vol":"23.98"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
资产负债率(%)	66.62	63.88	58.54	53.70	43.81
行业(%)	25.48	25.46	24.92	24.62	23.98

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-03-31","value":"2.00","vol":"0.78"},{"date":"2024-12-31","value":"1.77","vol":"0.88"},{"date":"2024-09-30","value":"1.41","vol":"0.41"},{"date":"2024-06-30","value":"1.16","vol":"0.38"},{"date":"2024-03-31","value":"0.78","vol":"0.36"}]

	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
产权比率 (%)	2.00	1.77	1.41	1.16	0.78
行业(%)	0.78	0.88	0.41	0.38	0.36

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
浦银国际	2025-05-02	中性
浙商证券	2025-04-30	买入
国投证券	2025-04-29	买入
光大证券	2025-04-11	买入
西部证券	2025-04-10	买入
长江证券	2025-04-09	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"2.76","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-9.99","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-15.11","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-14.68","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-9.35","blueLineValue":"-1.72","type":"YC"}]

[荣昌生物]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]